Loading chat...
MA H1222
Bill
Status
Introduced
2/27/2025
Primary Sponsor
Sally Kerans
Click for details
AI Summary
- Prohibits licensed health insurers from requiring annual re-authorizations for prescription drugs prescribed to treat chronic diseases
- Applies to insurers regulated under chapters 32A, 118E, 175, 176A, 176B, and 176G of Massachusetts General Laws (covering state employee insurance, MassHealth, and various commercial insurers)
- Covers prescriptions written by physicians, physician's assistants, or nurse practitioners
- Chronic diseases specifically listed include diabetes, heart disease, Alzheimer's disease, cancer, stroke, and respiratory disease
- Similar legislation was previously filed as House No. 3757 in the 2023-2024 session
Legislative Description
Relative to prescription medication re-authorization
Last Action
Reporting date extended to Wednesday, March 18, 2026
12/8/2025
Committee Referrals
Health Care Financing9/18/2025
Financial Services2/27/2025
Full Bill Text
No bill text available